273
Participants
Start Date
October 31, 2011
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
Revamilast
Tablet. Low dose, Once daily for 12 weeks
Revamilast
Medium dose, Once daily for 12 weeks
Revamilast
High dose, Once daily for 12 weeks
Placebo
Placebo tablet in triple dummy format, Once daily for 12 weeks
MAMC & Associated Lok Nayak Hospitals, New Delhi
Shwaas Center, Navkar Hospital, Jaipur
Prince Aly Khan Hospital, Mumbai
KRIMS Hospitals, Nagpur
Getwell Hospital & Research Institute, Nagpur
Indore Chest Centre, Indore
Vasavi Hospital and Research Centre, Hyderabad
Saboo hospital and research centre, Hyderabad
HORNMED s.r.o., Brno
Sdružená pneumologická a anesteziologická ambulance, Jindřichův Hradec
Private pulmonatory ambulance, Neratovice
Kunal Institute of Medical Specialities Pvt. Ltd, Hyderabad
Narayana Medical College & Hospital, Nellore
Yashoda Hospital, Secunderabad
T B and Chest Disease Hospital, Mormugao
Rutuja Allergy , Chest and General Clinic, Ponda
Gujarat Pulmonary & Critical Care Clinic, Ahmedabad
Chest and Maternity Centre, Bangalore
M S Ramaiah Medical College & Teaching Hospital, Bangalore
Narayanan Hrudayalaya Hospital, Bangalore
Kasturba Medical College Hospital, Mangalore
Westfort Hi-tech Hospital Ltd, Thrissur
The Bhatia Hospital, Mumbai
Chest Research Foundation, Pune
Asthma Bhawan, Jaipur
Dr Khippal's Clinic, Jaipur
Chennai Thoracic Research Institute, Chennai
Christian Medical College, Vellore
National Allergy Asthma Bronchitis Institute, Kolkata
NZOZ 'Promedica', Bialystok
Nzoz Clinica Vitae, Gdansk
Landa Specjalistyczne Gabinety Lekarskie, Krakow
Prywatna Praktyka Lekarska, Krakow
Prywatny Gabinet Specjalistyczny, Lodz
Cdt Medicus, Lubin
Centrum Alergologii Teresa Hofman, Poznan
Centrum Medyczne Lucyna Andrzej Dymek, Strzelce Opolskie
State Healthcare Institution, Elektrostal
Central Clinical Hospital of Russian Academy of Science, Moscow
State Healthcare Institution of Moscow, Moscow
State Educational Healthcare Institution, Saratov
London Chest Hospital Department of Respiratory Medicine, London
Lead Sponsor
Collaborators (1)
Glenmark Pharmaceuticals S.A.
INDUSTRY
Glenmark Pharmaceuticals Ltd. India
INDUSTRY